We are pleased to announce that Jennifer Che, Managing Director of Eagle IP, will be traveling to London from May 2 to May 6, 2026  in conjunction with the International Trademark Association (INTA) 2026 Annual Meeting..

If you or your team will be attending INTA2026 or will be in London during the first week of May, Jennifer would welcome the opportunity to meet for a coffee or a scheduled briefing. Please contact us to coordinate a time during the conference week.

Our Past Events

Pauli Wong gave a talk at Hong Kong Life Sciences Society (HKLSS)

10 October 2026

BioHK2026 | Biotech IP in practice

16 September 2026

Jennifer Che Once Again Named to the IAM Strategy 300

21 August 2026

Yolanda Wang attended the 1st China Pharmaceutical Innovation Conference

22 July 2026

Pauli Wong as a Guest speaker for “Entrepreneurial Workshop” in Poly U

16 June 2026

Eagle IP Recognized as Top Tier Firm (Tier 1) for Patent Prosecution in IP Stars 2026 Patent Firms Ranking List

5 June 2026

Recommended Insights

China Patent 2020 to 2021

China Provides Specific Directions to Strengthen Patent / Technology Protection from 2020 to 2021

23 April 2020
China continues to progress towards its major goal of significantly strengthening IP protection within its borders. Last year it announced several proposed amendments to its patent laws. In January 2020 China and the US signed the Economic and Trade Agreement between the Government of China and US (published 16 January 2020 –“Trade Agreement”), which detailed […]
Read more >

AI, Big Data, and Blockchain - CNIPA seeks public comment on draft patent examination guidelines

21 November 2019
Exciting new changes continue to happen with the Chinese Patent Office (CNIPA). On November 12, 2019, the CNIPA published a new set of amendments to Part II Chapter 9 of the Patent Examination Guidelines (“Draft”) and requested public comment by December 11, 2019. In summary, the new guidelines clarify how emerging technologies involving artificial intelligence, […]
Read more >

China’s Newest Examination Guidelines: Post-Filing Supplemental Data for Compounds (Part I)

28 April 2021
Post-filing data in China has been a constant issue for many patent practitioners around the world. Examiners seem to require it often, and yet the rules regarding when it is acceptable have seemed much stricter than other jurisdictions worldwide. In fact, we tried to summarize the latest state of the law in an earlier blog […]
Read more >

Chinese Courts Cares More About Patent Quality Now (A Doctrine of Equivalents Story)

13 December 2022
There is no doubt that the drafting quality of a patent can be crucial in determining the success (or failure!) of the patent during litigation. However, due to various reasons, patents often fail to use the right drafting strategies that best protect the invention. Too often, inexperienced or unsophisticated patent drafters merely listen to an […]
Read more >
Top crossarrow-right